Acute phase levels of C-reactive protein enhance IL-1β and IL-1ra production by human blood monocytes but inhibit IL-1β and IL-1ra production by alveolar macrophages

Journal of Immunology

Volumn 156, Issue 4, 1996, Pages 1594-1600

  Pue, Charles A ^a   Mortensen, Richard F ^a   Marsh, Clay B ^a   Pope, Heidi A ^a   Wewers, Mark D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ACUTE DISEASE; ARTICLE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

ACUTE-PHASE REACTION; ADULT; C-REACTIVE PROTEIN; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MONOCYTES; SIALOGLYCOPROTEINS;

EID: 0030023051     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Bone, R. C. 1991. Gram-negative sepsis: background, clinical features, and intervention Chest 100:802.
2. Dinarello, C. A 1991. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis 163: 1177.
3. Taveira da Silva, A. M , H. C Kaulbach, F. S Chuidian, D R. Lambert, A. F. Suffredini, and R. L. Danner 1993 Brief report. shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N. Engl. J. Med. 328: 1457.
4. Casey, L. C., R. A. Balk, and R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern. Med. 119:771.
5. Wewers, M D., J. J. Rinehart, Z.-W. She, D. J. Herzyk, M M. Hummel, P A. Kinney, and W B. Davis 1990. Tumor necrosis factor infusions in humans prime neutrophils for hypochlorous acid production. Am. J. Physiol. Lung Cell. Mol. Physiol. 259:L276
6. Elias, J. A., K. Gustilo, W. Baeder, and B. Freundlich. 1987. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J. Immunol 138:3812.
7. Schmidt, J. A., S. B. Mizel, D. Cohen, and I. Green. 1982. Interleukin 1. a potential regulator of fibroblast proliferation. J Immunol. 128:2177.
8. 2 production by human synovial cells. J. Clin. Invest. 77:645.
9. Mizel, S. B., J.-M. Dayer, S. M. Krane, and S. E. Mergenhagen. 1981. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interteukin 1). Proc. Natl Acad. Sci. USA 78:2474.
10. Mielke, V., J. G J. Bauman, M. Sticherling, T Ibs, A. G. Zomershoe, K. Seligmann, H.-H Henneicke, J -M Schröder, W Sterry, and E. Christophers 1990. Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1α- and human recombinant tumor necrosis factor-α-stimulated human dermal fibroblasts: an immunocytochemical and fluorescent in situ hybridization study. J Immunol 144:153.
11. DeForge, L. E., J S. Kenney, M L. Jones, J. S Warren, and D. G. Remick. 1992. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood: separation of LPS- and cytokine-stimulated components using antitumor necrosis factor and anti-IL-1 antibodies J Immunol. 148:2133
12. Strieter, R. M., S. L. Kunkel, H. J. Showell, D. G. Remick, S. H. Phan, P. A. Ward, and R. M. Marks 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS, and IL-1β. Science 243:1467.
13. Dinarello, C A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627.
14. Li, S. P., T. Y. Liu, and N. D. Goldman. 1990. cis-acting elements responsible for interleukin-6 inducible C-reactive protein gene expression J. Biol Chem. 265: 4136.
15. Ganter, U., R. Arcone, C. Toniatti, G. Morrone, and G Ciliberto. 1989. Dual control of C-reactive protein gene expression by IL-1 and IL-6. EMBO J. 83: 3773.
16. Ganapathi, M. K., D. Rzewnicki, D. Samols, S. L. Jiang, and I Kushner. 1991. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J. Immunol. 147:1261.
17. Ku, N. O., and R. F Mortensen. 1993. The mouse C-reactive protein (CRP) gene is expressed in response to IL-1 but not IL-6. Cytokine 5:319
18. Scheid, C , R Young, R. McDermott, L Fitzsimmons, J. H. Scarffe, and P. L. Stern. 1994. Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and iymphokine-activated killer cell activity. Cancer Immunol. Immunother 38:119.
19. Dowton, S. S , and H. R Colten. 1988. Acute phase reactants in inflammation and infection. Semin. Hematol. 25:84
20. Ballou, S., and I. Kushner. 1992. C-reactive protein and the acute phase response. Adv. Intern. Med 37:313.
21. Li, J. J., R. L. Sanders, K P. W. J McAdam, C. A. Hales, B T Thompson, J. A. Gelfand, and J. F. Burke. 1989. Impact of C-reactive protein (CRP) on surfactant function J Trauma 29:1690.
22. Kushner, I. 1988 The acute phase response: an overview. Methods Enzymol. 163:373
23. Zahedi, K , J M Tebo, J. Siripont, G. F. Klimo, and R. F. Mortensen. 1989. Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors. J. Immunol 142:2384.
24. Tebo, J M., and R F. Mortensen. 1990. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937. J. Immunol. 144:231.
25. Ballou, S., J. Buniel, and S. MacIntyre. 1989. Specific binding of human C-reactive protein to human monocytes in vitro. J. Immunol. 142:2708.
26. Ballou, S., and R. Cleveland 1991. Binding of human C-reactive protein to monocytes: analysis by flow cytometry. Clin. Exp Immunol. 84:329.
27. Zeller, J., B. Kubak, and H. Gewurz. 1989. Binding sites for C-reactive protein on human monocytes are distinct from IgG Fc receptors. Immunology 67:51.
28. Barna, B , K James, and S Deodbar. 1987. Activation of human monocyte tumoricidal activity by C-reactive protein. Cancer Res. 47:3959
29. Robey, F., K. Ohura, S. Futaki, N. Fujii, H. Yajima, N. Goldman, K. Jones, and S. Wahl. 1987. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. J. Biol. Chem. 262:7053.
30. Shephard, E., S DeBeer, R. Anderson, A Strachan, A. Nel, and F DeBeer. 1989. Generation of biologically active C-reactive protein peptides by a neutral protease on the membrane of phorbol myristate acetate-stimulated neutrophils J. Immunol. 4143: 2974.
31. Rochemonteix, B. G., K. Wiktorowicz, I Kushner, and J.-M Dayer. 1993. C-reactive protein increases production of IL-1α, IL-1β, and TNF-α, and expression of mRNA by human alveolar macrophages. J. Leukocyte Biol. 53:439.
32. Hokama, Y , S A A Honda, L A. Hanakahi, and K. Y. Terada. 1988. C-reactive protein and platelet activating factor complexes induce production and release of interleukin-1 by human monocytes. J. Clin. Lab. Anal 2:155.
33. Ballou, S P., and G Lozanski. 1992 Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein Cytokine 4:361.
34. Wewers, M D., and D. J Herzyk. 1989. Alveolar macrophages differ from blood monocytes in human interleukin 1β release: quantitation by enzyme linked immunoassay. J Immunol. 143:1635.
35. Wewers, M. D., H A Pope, and D. K. Miller. 1993. Processing proIL-1β decreases detection by a proIL-1β specific ELISA but increases detection by a conventional ELISA. J. Immunol. Methods 165:269.
36. Marsh, C. B., H A. Pope, and M. D. Wewers 1994. Fcγ receptor cross-linking down-regulates IL-1 receptor antagonist and induces IL-1β in mononuclear phagocytes stimulated with endotoxin or Staphylococcus aureus. J Immunol. 152:4604.
37. Roux, K., J. Kilpatrick, J. Volanakis, and J. Kearney. 1983. Localization of the phosphocholine-binding sites on C-reactive protein by immunoelectron microscopy. J. Immunol. 131:2411
38. Swanson, S , M. Mullenix, and R. Mortensen. 1991 Monoclonal antibodies to the calcium-binding region peptide of human C-reactive protein alter its conformation. J. Immunol. 147:2248.
39. Christner, R B., and R. F Mortensen 1994 Specificity of the binding interaction between human serum amyloid P-component and immobilized human C-reactive protein J Biol. Chem. 269:9768.
40. Shine, B , F. C DeBeer, and M. B Pepys. 1981. Solid phase radioimmunoassays for human C-reactive protein Clin. Chim. Acta 117:13.
41. Smith, M. F , Jr , D. Eidlen, M. T. Brewer, S P Eisenberg, W. P. Arend, and A. Gutierrez-Hartmann 1992. Human IL-1 receptor antagonist promoter: cell type-specific activity and identification of regulator regions J. Immunol. 149: 2000
42. Granowitz, E. V., A. A Santos, D D. Poutsiaka, J. G. Cannon, D. W. Wilmore, S. M. Wolff, and C. A Dinarello 1991. Production of interleukin-1-recepror antagonist during experimental endotoxaemia. Lancet 338:1423.
43. Cybulsky, M. I., M. K. W. Chan, and H. Z. Movat. 1988. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in Gram-negative infection. Lab Invest. 58:365
44. Tilg, H., E. Vannier, G. Vachino, C A Dinarello, and J. W. Mier. 1993. Anti-inflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells. J. Exp. Med 178:1629.
45. Wurfel, M. M., S. T. Kunitake, H. Lichenstein, J. P. Kane, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp. Med. 180:1025
46. Sammalkorpi, K T , V. Valtonen, and C P. J. Maury. 1990 Lipoproteins and acute phase response during acute infection: interrelationship between CRP and SAA. Ann. Med. 22:397.
47. Cabana, V., H. Gewurz, and J. Siegel. 1983. Inflammation-induced changes in rabbit CRP and plasma lipoproteins J. Immunol. 130:1736.
48. Shumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J D. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein Science 249:1429.
49. Cabana, V., H. Gewurz, and J. Siegel. 1982. Interaction of very low density Lipoproteins (VLDL) with rabbit C-reactive protein. J. Immunol. 128:2342.
50. DeBeer, F., A. Soutar, M. Baltz, I. Trayner, A. Feinstein, and M. Pepys 1982. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein J Exp. Med. 156:230.
51. Rowe, I., A. Soutar, M. Baltz, F. DeBeer, L. Walker, D. Bowyer, J. Hebert, A Feinstein, and M. Pepys. 1984. Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins. J. Exp. Med. 159:604.
52. Hance, A. J., S. Douches, R. J. Winchester, V. J. Ferrans, and R. G. Crystal 1985. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes m alveolar macrophage phenotype associated with pulmonary sarcoidosis. J. Immunol. 134:284.
53. Spurzem, J. R., C. Saltini, W. Rom, R. J. Winchester, and R. G. Crystal. 1987. Mechanisms of macrophage accumulation in the lungs of asbestos-exposed subjects. Am. Rev. Respir. Dis. 136:276.
54. Kushner, I., and M. H. Kaplan. 1961. Studies of acute phase protein. I. An immunohistochemical method of the localization of Cx-reactive protein in rabbits. J. Exp. Med. 114:961.
55. Kushner, I , L. Rakita, and M H. Kaplan. 1963. Studies of acute phase protein. II. Localization of Cx-reactive protein in heart in induced myocardial infarction in rabbits. J. Clin. Invest. 42:286.
56. Heuertz, R. M., D. Xia, D. Samols, and R. O. Webster. 1994. Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am J. Physiol Lung Cell. Mol. Physiol. 266:L649